Pages that link to "Q38325597"

The following pages link to PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes (Q38325597):

Displaying 20 items.

• The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion (Q28117802) (← links)
• Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity (Q28512562) (← links)
• Acute genome-wide effects of rosiglitazone on PPARγ transcriptional networks in adipocytes (Q33633063) (← links)
• Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages (Q34243620) (← links)
• The effect of n-3 long chain fatty acids supplementation on plasma peroxisome proliferator activated receptor gamma and thyroid hormones in obesity (Q36973992) (← links)
• Selective modulation of promoter recruitment and transcriptional activity of PPARgamma (Q36979694) (← links)
• Transcriptional and epigenetic mechanisms underlying enhanced in vitro adipocyte differentiation by the brominated flame retardant BDE-47. (Q37697325) (← links)
• Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes (Q39218842) (← links)
• Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: A novel cyclooxygenase-inhibition-independent effect (Q39490676) (← links)
• PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis (Q39753643) (← links)
• Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma (Q40752220) (← links)
• Novel method to differentiate 3T3 L1 cells in vitro to produce highly sensitive adipocytes for a GLUT4 mediated glucose uptake using fluorescent glucose analog (Q40914050) (← links)
• Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes (Q42506536) (← links)
• Serum-free differentiation of 3T3-L1 preadipocytes is characterized by only transient expression of peroxisome proliferator-activated receptor-gamma (Q42524285) (← links)
• Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation (Q42803719) (← links)
• Down-regulation of peroxisome proliferator-activated receptor-gamma gene expression by sphingomyelins (Q42830255) (← links)
• Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma (Q44021600) (← links)
• Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPARγ gene expression (Q51315432) (← links)
• PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? (Q72999922) (← links)
• Novel anti-cancer effects of indomethacin: exploring the cyclooxygenase-inhibition-independent effects (Q83818174) (← links)